902 related articles for article (PubMed ID: 11054026)
1. Isoform expression of CD44 adhesion molecules, Bcl-2, p53 and Ki-67 proteins in lung cancer.
Mizera-Nyczak E; Dyszkiewicz W; Heider KH; Zeromski J
Tumour Biol; 2001; 22(1):45-53. PubMed ID: 11054026
[TBL] [Abstract][Full Text] [Related]
2. Preferential histiotypic expression of CD44-isoforms in human lung cancer.
Wimmel A; Schilli M; Kaiser U; Havemann K; Ramaswamy A; Branscheid D; Kogan E; Schuermann M
Lung Cancer; 1997 Mar; 16(2-3):151-72. PubMed ID: 9152947
[TBL] [Abstract][Full Text] [Related]
3. Non-small cell lung carcinoma: cyclin D1, bcl-2, p53, Ki-67 and HER-2 proteins expression in resected tumors.
Radović S; Babić M; Dorić M; Hukić A; Kuskunović S; Hadzismajlović A; Serdarević F
Bosn J Basic Med Sci; 2007 Aug; 7(3):205-11. PubMed ID: 17848143
[TBL] [Abstract][Full Text] [Related]
4. Biological markers and DNA flow cytometric analysis in radically resected patients with non-small cell lung cancer. A study of the Perugia Multidisciplinary Team for Thoracic Tumors.
Ludovini V; Pistola L; Gregorc V; Floriani I; Rulli E; Di Carlo L; Semeraro A; Daddi G; Darwish S; Stocchi L; Tofanetti FR; Bellezza G; Sidoni A; Tognellini R; Crinò L; Tonato M
Tumori; 2008; 94(3):398-405. PubMed ID: 18705409
[TBL] [Abstract][Full Text] [Related]
5. Association of Ki-67, p53, and bcl-2 expression of the primary non-small-cell lung cancer lesion with brain metastatic lesion.
Bubb RS; Komaki R; Hachiya T; Milas I; Ro JY; Langford L; Sawaya R; Putnam JB; Allen P; Cox JD; McDonnell TJ; Brock W; Hong WK; Roth JA; Milas L
Int J Radiat Oncol Biol Phys; 2002 Aug; 53(5):1216-24. PubMed ID: 12128123
[TBL] [Abstract][Full Text] [Related]
6. HER-2/neu expression in archival non-small cell lung carcinomas using FDA-approved Hercep test.
Scheurle D; Jahanzeb M; Aronsohn RS; Watzek L; Narayanan R
Anticancer Res; 2000; 20(3B):2091-6. PubMed ID: 10928158
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of the tumor suppressor gene maspin in non-small cell lung cancer.
Hirai K; Koizumi K; Haraguchi S; Hirata T; Mikami I; Fukushima M; Yamagishi S; Kawashima T; Okada D; Shimizu K; Kawamoto M
Ann Thorac Surg; 2005 Jan; 79(1):248-53. PubMed ID: 15620951
[TBL] [Abstract][Full Text] [Related]
8. Expression of alternatively spliced forms of the CD44 extracellular-matrix receptor on human lung carcinomas.
Jackson DG; Schenker T; Waibel R; Bell JI; Stahel RA
Int J Cancer Suppl; 1994; 8():110-5. PubMed ID: 7515025
[TBL] [Abstract][Full Text] [Related]
9. Ku80 is differentially expressed in human lung carcinomas and upregulated in response to irradiation in mice.
Ye J; Ren Z; Gu Q; Wang L; Wang J
DNA Cell Biol; 2011 Dec; 30(12):987-94. PubMed ID: 21663524
[TBL] [Abstract][Full Text] [Related]
10. Predictive value of expression of P53, Bcl-2 and lung resistance-related protein for response to chemotherapy in non-small cell lung cancers.
Harada T; Ogura S; Yamazaki K; Kinoshita I; Itoh T; Isobe H; Yamashiro K; Dosaka-Akita H; Nishimura M
Cancer Sci; 2003 Apr; 94(4):394-9. PubMed ID: 12824911
[TBL] [Abstract][Full Text] [Related]
11. Bcl-2, p53, CD44, and CD44v6 isoform expression in neuroendocrine tumors of the lung.
Coppola D; Clarke M; Landreneau R; Weyant RJ; Cooper D; Yousem SA
Mod Pathol; 1996 May; 9(5):484-90. PubMed ID: 8733762
[TBL] [Abstract][Full Text] [Related]
12. Apoptosis occurs independently of bcl-2 and p53 over-expression in non-small cell lung carcinoma.
O'Neill AJ; Staunton MJ; Gaffney EF
Histopathology; 1996 Jul; 29(1):45-50. PubMed ID: 8818693
[TBL] [Abstract][Full Text] [Related]
13. Predictive survival markers in patients with surgically resected non-small cell lung carcinoma.
Moldvay J; Scheid P; Wild P; Nabil K; Siat J; Borrelly J; Marie B; Farré G; Labib T; Pottier G; Sesboüé R; Bronner C; Vignaud JM; Martinet Y; Martinet N
Clin Cancer Res; 2000 Mar; 6(3):1125-34. PubMed ID: 10741743
[TBL] [Abstract][Full Text] [Related]
14. [Preliminary study on relationship among apoptosis and related gene, prognosis of lung cancer].
Wang J; Wang Z; Chen M
Zhonghua Jie He He Hu Xi Za Zhi; 1997 Jun; 20(3):141-4. PubMed ID: 10072816
[TBL] [Abstract][Full Text] [Related]
15. The prognostic significance of p53 and bcl-2 expression in lung adenocarcinoma and its correlation with Ki-67 growth fraction.
Ishida H; Irie K; Itoh T; Furukawa T; Tokunaga O
Cancer; 1997 Sep; 80(6):1034-45. PubMed ID: 9305703
[TBL] [Abstract][Full Text] [Related]
16. The 3' UTR IGF2R-A2/B2 variant is associated with increased tumor growth and advanced stages in non-small cell lung cancer.
Kotsinas A; Evangelou K; Sideridou M; Kotzamanis G; Constantinides C; Zavras AI; Douglass CW; Papavassiliou AG; Gorgoulis VG
Cancer Lett; 2008 Feb; 259(2):177-85. PubMed ID: 18037232
[TBL] [Abstract][Full Text] [Related]
17. Relationship between E-cadherin gene mutation and p53 gene mutation, p53 accumulation, Bcl-2 expression and Ki-67 staining in diffuse-type gastric carcinoma.
Fricke E; Keller G; Becker I; Rosivatz E; Schott C; Plaschke S; Rudelius M; Hermannstädter C; Busch R; Höfler H; Becker KF; Luber B
Int J Cancer; 2003 Mar; 104(1):60-5. PubMed ID: 12532420
[TBL] [Abstract][Full Text] [Related]
18. ADAM8 as a novel serological and histochemical marker for lung cancer.
Ishikawa N; Daigo Y; Yasui W; Inai K; Nishimura H; Tsuchiya E; Kohno N; Nakamura Y
Clin Cancer Res; 2004 Dec; 10(24):8363-70. PubMed ID: 15623614
[TBL] [Abstract][Full Text] [Related]
19. Telomerase activity and Bcl-2 expression in non-small cell lung cancer.
Ohmura Y; Aoe M; Andou A; Shimizu N
Clin Cancer Res; 2000 Aug; 6(8):2980-7. PubMed ID: 10955774
[TBL] [Abstract][Full Text] [Related]
20. High prevalence of bcl-2 oncoprotein expression in small cell lung cancer.
Higashiyama M; Doi O; Kodama K; Yokouchi H; Tateishi R
Anticancer Res; 1995; 15(2):503-5. PubMed ID: 7763030
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]